Hypothesis: Efficacy of early treatments with some NSAIDs in COVID‐19: Might it also depend on their direct and/or indirect zinc chelating ability?. (8th December 2022)

• Record Type: Journal Article
• Authors: Zamai, Loris
• Is Part Of: British journal of pharmacology. Volume 180:Number 3(2023)
• Page Start: 279
• Page End: 286
• Publication Date: 2022-12-08
• Subjects: glutathione -- non‐steroidal anti‐inflammatory drugs -- paracetamol -- renin‐angiotensin system -- severe acute respiratory syndrome coronavirus 2 -- zinc chelation -- zinc metalloproteases; Pharmacology -- Periodicals; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1111/bph.15989
• Languages: English
• ISSNs: 0007-1188

Abstract

Abstract : The present work argues for the involvement of the zinc chelating ability of some non‐steroidal anti‐inflammatory drugs as an additive mechanism able to increase their efficacy against COVID‐19.